Chengdu Wision Medical Device
About Chengdu Wision Medical Device
Chengdu Wision Medical Device, operating as Wision A.I., is a healthcare AI company specializing in advanced diagnostic algorithms and systems for clinical imaging, primarily focusing on gastrointestinal endoscopy and histopathology. Their flagship product, EndoScreener, is an AI-assisted polyp detection software designed to enhance colonoscopy procedures. It provides real-time visual notifications and sound alarms to aid endoscopists in identifying polyps during colonoscopy, integrating seamlessly with most mainstream endoscope systems.
For physicians, EndoScreener offers significant clinical benefits by improving adenoma detection rates and reducing the miss rate of precancerous lesions. Clinical trials involving over 5,000 patients have demonstrated its efficacy, showing a reduction of 41% in precancerous lesion miss rate and a 33% improvement in adenoma per colonoscopy (APC). The software is a Class II medical device, having received CE Mark approval under the new Medical Devices Regulation (MDR 2017/745), FDA 510(k) clearance, and NMPA Class III approval. This technology aims to contribute to the prevention of colorectal cancer by facilitating earlier and more accurate detection, thereby optimizing patient outcomes and potentially reducing healthcare expenditures.
Beyond colonoscopy, Wision A.I. is also developing tools for histopathological diagnosis, such as an AI-based tool for whole slide localization of cancerous regions in tissue sample slides. The company emphasizes integrating medical knowledge with cutting-edge convolutional neural networks and general-purpose computing to achieve stable and robust detection efficacy in diagnostic imaging, with a focus on solving problems with smaller datasets and respecting the mathematical essence of deep learning.
Focus Areas
Business Intelligence
| Key Investors | MedTech Innovator, Northern Light Venture Capital |
| Partnerships | Micro-Tech Endoscopy USA (U.S. GI endoscopy distributor for EndoScreener) |
| Technology | Cloud-native (implied by 'scalable models' and 'general-purpose computing'), deep learning AI, convolutional neural networks (CNNs), Computer Aided Polyp Detection (CADe) systems |
| FDA Clearances | 1 cleared products (estimated) |
What Physicians Need to Know
For physicians, Chengdu Wision Medical Device's EndoScreener offers a powerful real-time assistant during colonoscopies, significantly improving polyp and adenoma detection rates and reducing the miss rate of precancerous lesions. While the AI provides visual and auditory alerts, it's crucial to remember that the system is intended to assist, not replace, the physician's medical judgment for confirming findings. The high compatibility and easy deployment of the software make it a practical addition to most existing endoscopy setups. Furthermore, their advancements in histopathology with AI-assisted HGD localization and 3D tumor reconstruction (PathoCruz 3D) promise to enhance diagnostic precision and streamline post-procedure assessments, ultimately contributing to better colorectal cancer screening and prevention.
Wision A.I.'s EndoScreener is designed as a software-only medical device (SaMD) that exhibits high compatibility with most mainstream endoscope systems. This allows for flexible deployment in various clinical environments without requiring extensive hardware overhauls. The system analyzes colonoscopy video streams in real-time, providing output directly overlaid onto the images.
What the Web Says
Chengdu Wision Medical Device Co., LTD, operating as Wision A.I., is a healthcare AI company that specializes in advanced diagnostic algorithms and systems, particularly for the detection of colorectal polyps. Their product, EndoScreener, is a computer-assisted detection device that analyzes colonoscopy video streams in real-time to highlight potential polyps with blue boxes and can also sound an alert. The EndoScreener has received FDA clearance and has been evaluated in multi-center clinical trials, demonstrating expected polyp detection accuracy and no significant imaging degradation or latency. The company's technology is noted for its use of deep learning and machine learning in medical imaging to enhance diagnostic accuracy and aid clinicians.
Overall: PositiveStrengths
- Automatically detects polyps using deep learning.
- Real-time analysis of colonoscopy video streams.
- Provides visual highlights (bounding boxes) and audio alerts for polyp detection.
- Demonstrated expected polyp detection accuracy in clinical trials.
- No significant imaging degradation or latency.
- FDA-cleared device.
Limitations
- Device is not intended for diagnosis or characterization of lesions, and does not replace clinical decision-making.
- Morphological evidence alone may not reveal molecular causes of illnesses or discriminate disease states with similar appearances.
- Limited information available on employer reviews or general company sentiment outside of product efficacy.
Based on reviews from: accessdata.fda.gov, American Journal of Gastroenterology, HealthAidb u2014 Software, Innolitics, Mazor Robotics - Physician Ai Tools, Novel research and future prospects of artificial intelligence in cancer diagnosis and treatment - PMC, The utility of artificial intelligence in visualization of pediatric gastrointestinal mucosa
Last updated: 2026-07-18
Videos
News, demos, and interviews about Chengdu Wision Medical Device.
Videos load interactively. If none appear, search YouTube for Chengdu Wision Medical Device →
Press & Coverage
Frequently Asked Questions
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]